|
1
|
Alliance OC and Group BC: What women and
their physicians need to know about the UKCTOCS study and ovarian
cancer screening. Am Fam Physician. 93:903–904. 2016.PubMed/NCBI
|
|
2
|
Shi Q, Wang XS, Li G, Shah ND, Orlowski
RZ, Williams LA, Mendoza TR and Cleeland CS: Racial/ethnic
disparities in inflammatory gene single-nucleotide polymorphisms as
predictors of a high risk for symptom burden in patients with
multiple myeloma 1 year after diagnosis. Cancer. 121:1138–1146.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferrara N: Microvascular density as a
predictive biomarker for bevacizumab survival benefit in ovarian
cancer: Back to first principles? J Natl Cancer Inst. 109:1092017.
View Article : Google Scholar
|
|
4
|
Kommoss S, Winterhoff B, Oberg AL, Konecny
GE, Wang C, Riska SM, Fan JB, Maurer MJ, April C, Shridhar V, et
al: Bevacizumab may differentially improve ovarian cancer outcome
in patients with proliferative and mesenchymal molecular subtypes.
Clin Cancer Res. 23:3794–3801. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mitsopoulos P, Lapohos O, Weraarpachai W,
Antonicka H, Chang YH and Madrenas J: Stomatin-like protein 2
deficiency results in impaired mitochondrial translation. PLoS One.
12:e01799672017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Conrad KA, Rodriguez R, Salcedo EC and
Rauceo JM: The Candida albicans stress response gene stomatin-like
protein 3 is implicated in ROS-induced apoptotic-like death of
yeast phase cells. PLoS One. 13:e01922502018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feng Q, Hu ZY, Liu XQ, Zhang X, Lan X,
Geng YQ, Chen XM, He JL, Wang YX and Ding YB: Stomatin-like protein
2 is involved in endometrial stromal cell proliferation and
differentiation during decidualization in mice and humans. Reprod
Biomed Online. 34:191–202. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang X, Zang W, Xuan X, Wang Z, Liu Z,
Wang J, Cui J and Zhao G: [Corrigendum] miRNA-1207-5p is associated
with cancer progression by targeting stomatin-like protein 2 in
esophageal carcinoma. Int J Oncol. 52:13632018.PubMed/NCBI
|
|
9
|
Küçük İ, Tanoğlu A, Öncü K, Yılmaz İ, Kara
M, Beyazıt Y, Akyol T, Kaplan M, Özarı HO and Yazgan Y:
Immunohistochemical activity of prohibitin-2 and stomatin-like
protein-2 in patients with ulcerative colitis. Turk J
Gastroenterol. 27:233–238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hauptmann S, Friedrich K, Redline R and
Avril S: Ovarian borderline tumors in the 2014 WHO classification:
Evolving concepts and diagnostic criteria. Virchows Arch.
470:125–142. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma W, Xu Z, Wang Y, Li W, Wei Z, Chen T,
Mou T, Cheng M, Luo J, Luo T, et al: A Positive feedback loop of
SLP2 activates MAPK signaling pathway to promote gastric cancer
progression. Theranostics. 8:5744–5757. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morgan RJ Jr, Armstrong DK, Alvarez RD,
Bakkum-Gamez JN, Behbakht K, Chen LM, Copeland L, Crispens MA,
DeRosa M, Dorigo O, et al: Ovarian cancer, version 1.2016, NCCN
clinical practice guidelines in oncology. J Natl Compr Canc Netw.
14:1134–1163. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Horikawa N, Abiko K, Matsumura N,
Hamanishi J, Baba T, Yamaguchi K, Yoshioka Y, Koshiyama M and
Konishi I: Expression of vascular endothelial growth factor in
ovarian cancer inhibits tumor immunity through the accumulation of
myeloid-derived suppressor cells. Clin Cancer Res. 23:587–599.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park JY, Kim DY, Suh DS, Kim JH, Kim YM,
Kim YT and Nam JH: Analysis of outcomes and prognostic factors
after fertility-sparing surgery in malignant ovarian germ cell
tumors. Gynecol Oncol. 145:513–518. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lutgendorf SK, Thaker PH, Arevalo JM,
Goodheart MJ, Slavich GM, Sood AK and Cole SW: Biobehavioral
modulation of the exosome transcriptome in ovarian carcinoma.
Cancer. 124:580–586. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chapel DB, Husain AN, Krausz T and
McGregor SM: PAX8 expression in a subset of malignant peritoneal
mesotheliomas and benign mesothelium has diagnostic implications in
the differential diagnosis of ovarian serous carcinoma. Am J Surg
Pathol. 41:1675–1682. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mei Y, Yao F, Wu Y, Chu B, Cheng C, Liu Y,
Li X, Zou X and Hou L: Identification and expression of the
elongator protein 2 (Ajelp2) gene, a novel regeneration-related
gene from the sea cucumber Apostichopus japonicus. Mol Biol
Rep. 41:4985–4996. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang L and Liu FJ: Expression of SLP-2
gene and CCBE1 are associated with prognosis of rectal cancer. Eur
Rev Med Pharmacol Sci. 21:1214–1218. 2017.PubMed/NCBI
|
|
20
|
Chi H and Hu YH: Stomatin-like protein 2
of turbot Scopthalmus maximus: Gene cloning, expression profiling
and immunoregulatory properties. Fish Shellfish Immunol.
49:436–441. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bartolome A, Boskovic S, Paunovic I, Bozic
V and Cvejic D: Stomatin-like protein 2 overexpression in papillary
thyroid carcinoma is significantly associated with high-risk
clinicopathological parameters and BRAFV600E mutation. APMIS.
124:271–277. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wai T and Langer T: Mitochondrial dynamics
and metabolic regulation. Trends Endocrinol Metab. 27:105–117.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang Y, Chen Y, Lin X, Lin Q, Han M and
Guo G: Clinical significance of SLP-2 in hepatocellular carcinoma
tissues and its regulation in cancer cell proliferation, migration,
and EMT. OncoTargets Ther. 10:4665–4673. 2017. View Article : Google Scholar
|
|
24
|
Deng H, Deng Y, Liu F, Chen J, Li Z, Zhao
K, Guan X and Liang W: Stomatin-like protein 2 is overexpressed in
cervical cancer and involved in tumor cell apoptosis. Oncol Lett.
14:6355–6364. 2017.PubMed/NCBI
|
|
25
|
Sun F, Ding W, He JH, Wang XJ, Ma ZB and
Li YF: Stomatin-like protein 2 is overexpressed in epithelial
ovarian cancer and predicts poor patient survival. BMC Cancer.
15:7462015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ardolino M and Raulet DH: Cytokine therapy
restores antitumor responses of NK cells rendered anergic in MHC
I-deficient tumors. OncoImmunology. 5:e10027252015. View Article : Google Scholar : PubMed/NCBI
|
